LXEO · Lexeo Therapeutics, Inc.
Market Cap
$409.41M
Shares
82.05M
Lexeo Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Lexeo Therapeutics, Inc. (LXEO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Earnings call
FY26 · Q2
2026-08-12
Lexeo Therapeutics, Inc. (LXEO) Q2 2026 Earnings Call Transcript
Confident tone
LX2006 Pivotal Study Design (Sunrise FA2)
Regulatory Pathway and FDA Engagement
LX2006 Efficacy and Safety Data (Phase 1/2)
Diluted EPS
$-0.30
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-11
Lexeo Therapeutics, Inc. (LXEO) Q1 2026 Earnings Call
Diluted EPS
$-0.25
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-30
Lexeo Therapeutics, Inc. (LXEO) Q4 2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–3 of 3 earnings calls
Key facts
CIK
1907108
CUSIP
52886X107
13F (30d)
131 filings
125 filers
Visit website
Investor relations